tetano
Editor, Senior Moderator
J Neurosurg Case Lessons
. 2023 Feb 6;5(6):CASE22487.
doi: 10.3171/CASE22487. Print 2023 Feb 6.
Developmental venous anomaly thrombosis in a patient with coronavirus disease 2019-associated hypercoagulability: illustrative case
Natasha Ironside[SUP] 1 [/SUP], Derek Petrosian[SUP] 1 [/SUP], Salma Abbas[SUP] 2 [/SUP], Ching-Jen Chen[SUP] 3 [/SUP], Ryan Kellogg[SUP] 1 [/SUP], Dale Ding[SUP] 4 [/SUP], Min S Park[SUP] 1 [/SUP]
Affiliations
Abstract
Background: Spontaneous thrombosis of a developmental venous abnormality (DVA) is a rare complication associated with hypercoagulability. The objective of this case report is to describe an association between DVA thrombosis and mild coronavirus disease 2019 (COVID-19) infection in a vaccinated patient.
Observations: A 28-year-old male with hypertension presented with severe headache and left-sided hemiparesis. Five weeks prior to presentation, the patient experienced mild respiratory symptoms and tested positive for COVID-19. Admission brain computed tomography (CT) showed a large right parieto-occipital intracerebral hemorrhage with surrounding edema. CT venography and catheter angiography showed a thrombosed DVA with associated venous infarction as the hemorrhage etiology. He was treated with decompressive hemicraniectomy, external ventricular drain placement, and systemic anticoagulation. The patient was functionally independent (modified Rankin Scale score, 2) at 4-month follow-up. Hypercoagulability work-up was unremarkable.
Lessons: Delayed DVA thrombosis after the COVID-19 infectious period may represent an association between the infection and a protracted systemic viral-induced hypercoagulable state. The severity of COVID-19 symptomatology does not appear to correlate with risk of DVA thrombosis. Young patients with a recent history of COVID-19 infection who present with venous infarction should be evaluated for an underlying thrombosed DVA.
Keywords: COVID-19; SARS-CoV-2; case report; developmental venous anomaly; severe acute respiratory syndrome coronavirus 2; stroke; thrombosis; venous infarction.
. 2023 Feb 6;5(6):CASE22487.
doi: 10.3171/CASE22487. Print 2023 Feb 6.
Developmental venous anomaly thrombosis in a patient with coronavirus disease 2019-associated hypercoagulability: illustrative case
Natasha Ironside[SUP] 1 [/SUP], Derek Petrosian[SUP] 1 [/SUP], Salma Abbas[SUP] 2 [/SUP], Ching-Jen Chen[SUP] 3 [/SUP], Ryan Kellogg[SUP] 1 [/SUP], Dale Ding[SUP] 4 [/SUP], Min S Park[SUP] 1 [/SUP]
Affiliations
- PMID: 36748755
- DOI: 10.3171/CASE22487
Abstract
Background: Spontaneous thrombosis of a developmental venous abnormality (DVA) is a rare complication associated with hypercoagulability. The objective of this case report is to describe an association between DVA thrombosis and mild coronavirus disease 2019 (COVID-19) infection in a vaccinated patient.
Observations: A 28-year-old male with hypertension presented with severe headache and left-sided hemiparesis. Five weeks prior to presentation, the patient experienced mild respiratory symptoms and tested positive for COVID-19. Admission brain computed tomography (CT) showed a large right parieto-occipital intracerebral hemorrhage with surrounding edema. CT venography and catheter angiography showed a thrombosed DVA with associated venous infarction as the hemorrhage etiology. He was treated with decompressive hemicraniectomy, external ventricular drain placement, and systemic anticoagulation. The patient was functionally independent (modified Rankin Scale score, 2) at 4-month follow-up. Hypercoagulability work-up was unremarkable.
Lessons: Delayed DVA thrombosis after the COVID-19 infectious period may represent an association between the infection and a protracted systemic viral-induced hypercoagulable state. The severity of COVID-19 symptomatology does not appear to correlate with risk of DVA thrombosis. Young patients with a recent history of COVID-19 infection who present with venous infarction should be evaluated for an underlying thrombosed DVA.
Keywords: COVID-19; SARS-CoV-2; case report; developmental venous anomaly; severe acute respiratory syndrome coronavirus 2; stroke; thrombosis; venous infarction.